Showing results (31-40 of 388) with videos related to
Sort By:
Pageof 39
Drug Discovery Today|August 29, 2015
Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial librariesXueshun Wang, Boshi Huang, Xinyong Liu, et al.Pharmaceutical Science Advances|January 19, 2026
Conquering viral drug resistance: Structural and mechanistic paradigms for antiresistance drug designMei Wang, Haiyong Jia, Xinyong Liu, et al.Mini Reviews in Medicinal Chemistry|October 16, 2008
Recent advances in the research of HIV-1 RNase H inhibitorsFang Yu, Xinyong Liu, Peng Zhan, et al.Mini Reviews in Medicinal Chemistry|July 16, 2009
Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIsPeng Zhan, Zhenyu Li, Xinyong Liu, et al.Journal of Medicinal Chemistry|October 29, 2015
Anti-HIV Drug Discovery and Development: Current Innovations and Future TrendsPeng Zhan, Christophe Pannecouque, Erik De Clercq, et al.Current Pharmaceutical Design|January 13, 2012
Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitorsWenwen Chen, Peng Zhan, Erik De Clercq, et al.Expert Opinion on Therapeutic Patents|April 22, 2025
A patent review of anti-coronavirus agents targeting the spike-ACE2 interaction (2019-present)Xing Huang, Heng Gao, Jiwei Zhang, et al.Drug Discoveries & Therapeutics|March 21, 2014
Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosisJinhua Chen, Wenfang Wang, Hongyuan Wang, et al.European Journal of Medicinal Chemistry|November 29, 2024
Recent advances in screening methods enabling the discovery of novel anti-hepatitis B virus drug candidatesYu Jin, Shuo Wang, Kai Tang, et al.Current Pharmaceutical Design|May 25, 2012
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO familyWenmin Chen, Peng Zhan, Jingde Wu, et al.Pageof 39